Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2014 Feb 27;97(1):55-63.
doi: 10.1016/j.lfs.2013.09.011. Epub 2013 Sep 23.

Moving around the molecule: relationship between chemical structure and in vivo activity of synthetic cannabinoids

Affiliations
Review

Moving around the molecule: relationship between chemical structure and in vivo activity of synthetic cannabinoids

Jenny L Wiley et al. Life Sci. .

Abstract

Originally synthesized for research purposes, indole- and pyrrole-derived synthetic cannabinoids are the most common psychoactive compounds contained in abused products marketed as "spice" or "herbal incense." While CB1 and CB2 receptor affinities are available for most of these research chemicals, in vivo pharmacological data are sparse. In mice, cannabinoids produce a characteristic profile of dose-dependent effects: antinociception, hypothermia, catalepsy and suppression of locomotion. In combination with receptor binding data, this tetrad battery has been useful in evaluation of the relationship between the structural features of synthetic cannabinoids and their in vivo cannabimimetic activity. Here, published tetrad studies are reviewed and additional in vivo data on synthetic cannabinoids are presented. Overall, the best predictor of likely cannabimimetic effects in the tetrad tests was good CB1 receptor affinity. Further, retention of good CB1 affinity and in vivo activity was observed across a wide array of structural manipulations of substituents of the prototypic aminoalkylindole molecule WIN55,212-2, including substitution of an alkyl for the morpholino group, replacement of an indole core with a pyrrole or phenylpyrrole, substitution of a phenylacetyl or tetramethylcyclopropyl group for JWH-018's naphthoyl, and halogenation of the naphthoyl group. This flexibility of cannabinoid ligand-receptor interactions has been a particular challenge for forensic scientists who have struggled to identify and regulate each new compound as it has appeared on the drug market. One of the most pressing future research needs is determination of the extent to which the pharmacology of these synthetic cannabinoids may differ from those of classical cannabinoids.

Keywords: Alkylindoles; Aromatic stacking; Cannabinoids; Herbal marijuana; Indoles; JWH-018; Pyrroles; Review; Spice; Synthetic cannabinoids.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest statement

The authors do not have any real or perceived conflicts of interest with regard to the data presented in this manuscript.

Figures

Figure 1
Figure 1
Historical 3-point attachment model used to develop JWH-018. An overlay of WIN55,212-2, Δ9-THC and JWH-018 was hypothesized, in which each cannabinoid would attach to the CB1 receptor at the 3 locations specified in the figure.
Figure 2
Figure 2
Effects of WIN55,212-2 on spontaneous activity (panel A), antinociception (panel B), rectal temperature (panel C), and catalepsy (panel D) in adult male ICR mice. Spontaneous activity was measured as total number of photocell beam interruptions during a 10-min session and is shown as % inhibition of activity of the vehicle group. Antinociception in a tail flick assay is expressed as the percent maximum possible effect (MPE) using a 10-s maximum test latency as follows: [(test−control)/(10−control)]×100. Rectal temperature values are expressed as the difference between control temperature (before injection) and temperature following drug administration (Δ°C). During assessment for catalepsy, the total amount of time (in s) that the mouse remained motionless on the ring apparatus (except for breathing and whisker movement) was measured and was used as an indication of catalepsy-like behavior. This value was divided by 300 s and multiplied by 100 to obtain percent immobility, as shown in the figure. Values represent the mean (± SEM) of 5–6 mice per group. The typical maximal effect observed for each measure is shown in the box at the upper left of each panel. ED50s for data presented in these panels are provided in Table 1.
Figure 3
Figure 3
Templates for major structural classes of synthetic cannabinoids discussed in this review: naphthoylindoles, naphthoylpyrroles, 1-pentyl-3-phenylacetylindoles and tetramethylcyclopropyl ketone indoles. Additional structural templates are shown in the tables.

References

    1. Aung MM, Griffin G, Huffman JW, Wu M, Keel C, Yang B, Showalter VM, Abood ME, Martin BR. Influence of the N-1 alkyl chain length of cannabimimetic indoles upon CB(1) and CB(2) receptor binding. Drug Alcohol Depend. 2000;60:133–40. - PubMed
    1. Breivogel CS, Childers SR. Cannabinoid agonist signal transduction in rat brain: comparison of cannabinoid agonists in receptor binding, G-protein activation, and adenylyl cyclase inhibition. J Pharmacol Exp Ther. 2000;295:328–36. - PubMed
    1. Brents LK, Gallus-Zawada A, Radominska-Pandya A, Vasiljevik T, Prisinzano TE, Fantegrossi WE, Moran JH, Prather PL. Monohydroxylated metabolites of the K2 synthetic cannabinoid JWH-073 retain intermediate to high cannabinoid 1 receptor (CB1R) affinity and exhibit neutral antagonist to partial agonist activity. Biochem Pharmacol. 2012;83:952–61. - PMC - PubMed
    1. Compton DR, Aceto MD, Lowe J, Martin BR. In vivo characterization of a specific cannabinoid receptor antagonist (SR141716A): inhibition of delta 9-tetrahydrocannabinol-induced responses and apparent agonist activity. J Pharmacol Exp Ther. 1996;277:586–94. - PubMed
    1. Compton DR, Gold LH, Ward SJ, Balster RL, Martin BR. Aminoalkylindole analogs: cannabimimetic activity of a class of compounds structurally distinct from delta 9-tetrahydrocannabinol. J Pharmacol Exp Ther. 1992;263:1118–26. - PubMed

Publication types

MeSH terms